Explore the JACC CKM Guideline Spotlight Issue, featuring perspectives on obesity management, HF prevention, diabetes care and Guideline implementation.

Three new studies provide insights into ATTR-CM, finding that delayed diagnosis worsens outcomes and that acoramidis can significantly slow declines in HF-related health status.

ADVANCE OUTCOMES found ralinepag reduced clinical worsening in PAH patients, though treatment discontinuations due to adverse events were higher.